Community oncologists are getting a masterclass in smarter cancer care: take your time, get second opinions, and choose precision over speed. Dr. Martin Dietrich is advising physicians treating ROS1-positive non-small cell lung cancer to build telemedicine access to expert consultations into their workflow, emphasizing that a thoughtful first treatment choice matters far more than rushing into a decision.

The reasoning is both practical and compelling. When an initial therapy underperforms, it can trigger drug resistance that makes later treatments less effective—even the newer, theoretically superior ones. Getting it right the first time isn't just better medicine; it's smarter long-term strategy for patient outcomes. This approach represents a broader shift in oncology toward personalized, deliberate treatment planning rather than one-size-fits-all protocols. Read the full story →

Today's takeaway: The future of cancer treatment hinges on precision and patience, not just speed.